About (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane
(6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane (PubChem CID 95848013) has the molecular formula C16H23N5O
and a molecular weight of 301.39 g/mol. Its IUPAC name is (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane.
Molecular Properties
| Compound Name | (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane |
| PubChem CID | 95848013 |
| Molecular Formula | C16H23N5O |
| Molecular Weight | 301.39 g/mol |
| Exact Mass | 301.19 |
| IUPAC Name | (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane |
| SMILES | Cc1cnc(C[C@H]2COCCN(Cc3nccn3C)C2)cn1 |
| InChI | InChI=1S/C16H23N5O/c1-13-8-19-15(9-18-13)7-14-10-21(5-6-22-12-14)11-16-17-3-4-20(16)2/h3-4,8-9,14H,5-7,10-12H2,1-2H3/t14-/m1/s1 |
| InChIKey | MDABJYYRLCSHJR-CQSZACIVSA-N |
| XLogP | 1.21 |
| TPSA | 56.07 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 301.39 |
| LogP ≤ 5 | 1.21 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane?
The IUPAC name of (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane (CID 95848013) is (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane.
What is the SMILES notation for (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane?
The canonical SMILES for (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane is Cc1cnc(C[C@H]2COCCN(Cc3nccn3C)C2)cn1.
What is the InChIKey of (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane?
The InChIKey is MDABJYYRLCSHJR-CQSZACIVSA-N. The full InChI is InChI=1S/C16H23N5O/c1-13-8-19-15(9-18-13)7-14-10-21(5-6-22-12-14)11-16-17-3-4-20(16)2/h3-4,8-9,14H,5-7,10-12H2,1-2H3/t14-/m1/s1.
What are the key properties of (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane?
(6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane has a molecular weight of 301.39 g/mol, XLogP of 1.21, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (6R)-4-[(1-methylimidazol-2-yl)methyl]-6-[(5-methylpyrazin-2-yl)methyl]-1,4-oxazepane is sourced from PubChem (CID 95848013), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).